Biopharma Co. Seelos Gets OK For $22M Ch. 11 Sale
A New York bankruptcy judge on Wednesday approved the $22 million credit bid sale of bankrupt biopharmaceutical company Seelos Therapeutics after hearing the buyer had agreed to add another $100,000 in...To view the full article, register now.
Already a subscriber? Click here to view full article